Wealthcare Advisory Partners’s Avanos Medical AVNS Stock Holding History

Wealthcare Advisory Partners’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-58	Closed	-$3K	–	647
2021 Q1	$3K	Buy	+58	New	+$2.72K	﹤0.01%	1761
2020 Q2	–	Sell	-83	Closed	-$2K	–	388
2020 Q1	$2K	Sell	83 -25	-23%	-$747	﹤0.01%	1266
2019 Q4	$4K	Hold	108	–	–	﹤0.01%	1128
2019 Q3	$4K	Hold	108	–	–	﹤0.01%	1095
2019 Q2	$5K	Hold	108	–	–	﹤0.01%	1043
2019 Q1	$5K	Hold	108	–	–	﹤0.01%	953
2018 Q4	$5K	Hold	108	–	–	﹤0.01%	917
2018 Q3	$7K	Hold	108	–	–	﹤0.01%	921
2018 Q2	$6K	Buy	108 +50	+86%	+$2.64K	﹤0.01%	938
2018 Q1	$3K	Sell	58 -79	-58%	-$3.75K	﹤0.01%	897
2017 Q4	$6K	Buy	137 +78	+132%	+$3.58K	﹤0.01%	749
2017 Q3	$3K	Buy	+59	New	+$2.52K	﹤0.01%	709

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wealthcare Advisory Partners's AVNS Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Avanos Medical (AVNS) in Q2 2021, closing a stake of 58 shares — an estimated $3K sold.

Wealthcare Advisory Partners first reported a position in AVNS in Q3 2017 and held it in 12 quarters. The position peaked at $7K in Q3 2018. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2021.

Wealthcare Advisory Partners reported no remaining Avanos Medical position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 58 Avanos Medical shares in Q2 2021, an estimated $3K.
Wealthcare Advisory Partners first reported a position in Avanos Medical in Q3 2017 and held it in 12 quarters.
Wealthcare Advisory Partners's Avanos Medical position peaked at $7K in Q3 2018.
274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.